Literature DB >> 7842297

Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus.

C M Morris1, J M Kerwin, J A Edwardson.   

Abstract

Increased free radical production may occur in Alzheimer's disease (AD). In view of the central role of iron in free radical reactions we have investigated the distribution of non-haem iron in the hippocampal formation in normal control individuals and in patients with AD. In controls, non-haem iron was principally associated with glial elements and the neuropil, with highest levels in the stratum radiatum/lacunosum, fimbria, alveus and oriens layers. Except for the subiculum, the pyramidal cell layers and the granule cell layer showed little or no non-haem iron staining. Intensity of staining was in the order of subiculum >> CA2 and adjacent regions of CA3 > CA4 > the remainder of CA3 > CA1. In the hippocampus in AD, iron was associated with cells containing neurofibrillary tangles (NFT) and was present in glial cells and neurites of senile plaques (SP). These findings were most pronounced in CA1 pyramidal cell layer and subicular complex although not all NFT or SP were stained. Since the NFT and SP staining for non-haem iron appears to be associated with glial cells, the association of non-haem iron with the pathological stigmata of AD may be a secondary response of glial cells, in particular microglia, to neuronal damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7842297

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  13 in total

1.  Volume and iron content in basal ganglia and thalamus.

Authors:  Patrice Péran; Andrea Cherubini; Giacomo Luccichenti; Gisela Hagberg; Jean-François Démonet; Olivier Rascol; Pierre Celsis; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

2.  High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron.

Authors:  Vijay Antharam; Joanna F Collingwood; John-Paul Bullivant; Mark R Davidson; Saurav Chandra; Albina Mikhaylova; Mary E Finnegan; Christopher Batich; John R Forder; Jon Dobson
Journal:  Neuroimage       Date:  2011-08-16       Impact factor: 6.556

3.  Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults.

Authors:  E Mark Haacke; Yanwei Miao; Manju Liu; Charbel A Habib; Yashwanth Katkuri; Ting Liu; Zhihong Yang; Zhijin Lang; Jiani Hu; Jianlin Wu
Journal:  J Magn Reson Imaging       Date:  2010-09       Impact factor: 4.813

4.  Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease.

Authors:  F J Jiménez-Jiménez; F de Bustos; J A Molina; J Benito-León; A Tallón-Barranco; T Gasalla; M Ortí-Pareja; F Guillamón; J C Rubio; J Arenas; R Enríquez-de-Salamanca
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases.

Authors:  H M Schipper
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

Review 6.  Therapeutics for Alzheimer's disease based on the metal hypothesis.

Authors:  Ashley I Bush; Rudolph E Tanzi
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

7.  Ferritin light chain interacts with PEN-2 and affects γ-secretase activity.

Authors:  Xinxin Li; Yiqian Liu; Qiuyang Zheng; Guorui Yao; Peng Cheng; Guojun Bu; Huaxi Xu; Yun-wu Zhang
Journal:  Neurosci Lett       Date:  2013-05-15       Impact factor: 3.046

8.  Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

Authors:  K J H Robson; D J Lehmann; V L C Wimhurst; K J Livesey; M Combrinck; A T Merryweather-Clarke; D R Warden; A D Smith
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

9.  Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level.

Authors:  Georg Nübling; Benedikt Bader; Johannes Levin; Jenna Hildebrandt; Hans Kretzschmar; Armin Giese
Journal:  Mol Neurodegener       Date:  2012-07-23       Impact factor: 14.195

10.  Ceruloplasmin/Transferrin ratio changes in Alzheimer's disease.

Authors:  Rosanna Squitti; Carlo Salustri; Mariacristina Siotto; Mariacarla Ventriglia; Fabrizio Vernieri; Domenico Lupoi; Emanuele Cassetta; Paolo M Rossini
Journal:  Int J Alzheimers Dis       Date:  2010-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.